On May 29, JMP Securities Silvan Tuerkcan revised the firm’s view on Taysha Gene Therapies, Inc. (NASDAQ: TSHA ), raising the ...

Citizens JMP lowered the firm’s price target on Prothena Corporation plc (NASDAQ:PRTA) to $29 from $78 but kept an Outperform ...

Analysts at JMP Securities remain optimistic about Caesars Entertainment, Inc. (NASDAQ:CZR), restating their Market ...

Desktop client using jellyfin-web with embedded MPV player. Supports Windows, Mac OS, and Linux. Media plays within the same window using the jellyfin-web interface unlike Jellyfin Desktop. Supports ...

Fintel reports that on May 22, 2025, JMP Securities initiated coverage of TeraWulf (NasdaqCM:WULF) with a Market Outperform ...

Fintel reports that on May 22, 2025, JMP Securities initiated coverage of Applied Digital (NasdaqGS:APLD) with a Market ...

On the positive side, the analyst noted that CoreWeave has a low-cost, high-density infrastructure used initially for bitcoin ...

LONDON, May 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that Chief Executive Officer Michael Parini will present a corporate overview at the Citizens JMP 2025 Life Sciences ...

On Wednesday, JMP Securities reiterated its Market Outperform rating on Abivax (NASDAQ: ABVX) with a steady price target of $33.00, significantly above the current trading price of $7.12.The firm’s ...

On Monday, JMP Securities analyst Greg Miller maintained a Market Outperform rating on Digital Realty Trust (NYSE:DLR) with a steady price target of $220.00. Miller’s analysis followed the company’s ...

JMP Securities reiterated a Market Outperform rating on Cytokinetics, maintaining a $78 price target, largely driven by optimism surrounding the MAPLE-HCM trial of aficamten, a treatment for ...